Gilead Sciences, Inc. operates in the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Gilead Sciences with three other
companies in this sector in the United States:
sales of $13.45 billion
of which 81%
was Product revenues, net),
of which 78%
was Bioscience), and
of which 21%
Gilead Sciences reported sales of $22.13 billion
December of 2018.
decrease of 15.2%
versus 2017, when the company's sales were $26.11 billion.